The current place of progestins in the treatment of endometriosis

References

• Hammond CB, Haney AF. Conservative treatment of endometriosis. Fertil. Steril.30, 497–509 (1978).
   PubMed Web of Science ®Google Scholar
• Kauppila A, Rönnberg L, Viehko R. Steroidrezeptoren in endometrischem. Gewebe Endometriose4, 56–59 (1986).
   Google Scholar
• Vierikko P, Kauppila A, Rönnberg L, Viehko R. Steroidal regulation of endometriosis tissue. Fertil. Steril.43, 218–223 (1985).
   PubMed Web of Science ®Google Scholar
• Obolensky W, Kamber J. Therapie der endometriose mit dydrogesteron in depot form. Ther. Umsch.30, 558–562 (1973).
   PubMedGoogle Scholar
• Schweppe K-W. Klinik und morphologie der endometriose. Schattauer, Stuttgart Germany, 133–150 (1984).
   Google Scholar
• Zeitoun KM, Takayama K, Sasano H et al. Deficient 17β-hydroxisteroid dehydrogenase type 2 expression in endometriosis. Failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab.83, 4474–4478 (1998).
   PubMed Web of Science ®Google Scholar
• Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum. Reprod. Update.12, 49–56 (2006).
   PubMed Web of Science ®Google Scholar
• Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear kappa B inactivation in endometriotic stromal cells. Fertil. Steril.83, 1530–1535 (2005).
   PubMed Web of Science ®Google Scholar
• Katayama H, Katayama T, Uematsu K et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model. Hum. Reprod.25, 2851–2858 (2010).
   PubMed Web of Science ®Google Scholar
• Fu L, Osuga Y, Morimoto C et al. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cell. Fertil. Steril.89(Suppl. 3), 1344–1347 (2008).
   PubMed Web of Science ®Google Scholar
• Timmonen S, Johansson CJ. Endometriosis treated with lynestrenol. Ann. Chir. Gynaecol.57, 144–147 (1968).
   Google Scholar
• Andrews MC, Andrews WC, Strauss AF. Effects of progestin induced pseudopregnancy on endometriosis: clinical and microscopic studies. Am. J. Obstet. Gynecol.78, 776–787 (1959).
   PubMed Web of Science ®Google Scholar
• Seliger E, Kaltwasser P, Schneider F, Rothe K, Röpke F. Behandlung der Endometriose mit Dienogest – Einfluss auf den Rezeptorstatus im Endometrium und vergleichende Bindungsstudien. In: Dienogest –Präklinik und Klinik eines Gestagens. Teichmann AT (Ed.), W de Gruyter Verlag, Berlin, Germany, 231–243 (1995).
   Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Europ. J. Obst. Gynec.151, 193–198 (2010).
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolideacetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum. Reprod.25, 633–641 (2010).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Hornung D, Seitz C et al. Reduced pelvic pain in endometriotic women: efficacy of a long term dienogest treatment persisting during the treatment-free follow up. Arch. Gynecol. Obstet. doi:10.1007/s00404-011-1941-1971 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Kuhl H. Comparative pharmacology of newer progestogens. Drugs51, 188–215 (1996).
   PubMed Web of Science ®Google Scholar
• Zimmermann H, Duvauchelle T, Gualano V, Kaufmann G, Bervoas-Martin S, Breitbarth H. Pharmacokinetics of dienogest as a single drug or in combination with estradiol valerate or ethinylestradiol. Drugs Today35(Suppl. C), 27–39 (1999).
   PubMedGoogle Scholar
• Telimaa S, Puolakka J, Rönnberg I, Kauppila A. Placebo controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol. Endocrinol.1, 13–19 (1987).
   PubMedGoogle Scholar
• Telimaa S, Rönnberg L, Kauppila A. Placebo controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol. Endocrinol.1, 363–371 (1987).
   PubMedGoogle Scholar
• Schweppe K-W. Einsatz der gestagene zur behandlung der endometriose – medrogeston versus danazol. In: Menopause aktuell. Schindler AE, Ebert CH (Eds), Aesopus, Basel, Switzerland, 85–93 (1996).
   Google Scholar
• Special Interest Group for Endometriosis and Endometrium. ESHRE Guideline for the Diagnosis and Management of Endometriosis. Hum. Reprod.20, 2698–2704 (2005).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O et al. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil. Steril.84, 1375–1387 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Seracchioli R et al. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum. Reprod.24, 3033–3041 (2009).
   PubMed Web of Science ®Google Scholar
• Vercellini P, De Giorgi O, Mosconi P et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil. Steril.77, 52–61 (2002).
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Theorell T. Changes in quality of life after hormonal treatment of endometriosis. Acta. Obstet. Gynecol. Scand.80, 628–637 (2001).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Trespidi L, Vendola N. A gonadotropin releasing hormone agonist versus a low dose OC for pelvic pain associated with endometriosis. Fertil. Steril.60, 75–79 (1993).
   PubMed Web of Science ®Google Scholar
• Regidor PA, Regidor M, Schmidt M et al. Prospective randomized study comparing the GnRH agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol. Endocrinol.15(3), 202–209 (2001).
   PubMed Web of Science ®Google Scholar
• Schweppe K-W. The place of dydrogesterone in the treatment of endometriosis and adenomyosis related lower abdominal pain and bleeding disorders. Maturitas65, 23–27 (2009).
   PubMed Web of Science ®Google Scholar
• Bishop PMF. A new oral progestogen in the treatment of dysmenorrhoea. Proc. Royal Soc. Med.9, 752–754 (1961).
   Google Scholar
• Fairweather DVI. Duphaston in dysmenorrhoea. J. Obst. Gyn. Br. Comm.72, 193–195 (1965).
   PubMedGoogle Scholar
• Aydar CK, Coleman BD. Treatment of primary dysmenorrhea. A double blind study. JAMA192, 1003–1005 (1965).
   PubMed Web of Science ®Google Scholar
• Schellen AACM, Wesselius de Casparis A. Treatment of dysmenorrhoea with dydrogesterone. Results of a double blind trial. Bull. Soc. Royale Belge Gynécol. Obstét.37, 273–276 (1967).
   PubMedGoogle Scholar
• Gould CHD. Dydrogesterone in the teenage dysmenorrhea. Practitioner222, 718–723 (1979).
   PubMedGoogle Scholar
• Ohlenroth G, Hatzmann W. Die therapie der juvenilen dysmenorrhö mit 6-dehydro-retro-progesteron. Med. Welt.33, 645–648 (1982).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Aimi G, Panazza S, De Giorgi O, Pesole A. Crosignani PG. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhoea associated with endometriosis: a pilot study. Fertil. Steril.72, 505–508 (1999).
   PubMed Web of Science ®Google Scholar
• Vercellini P, De Giorgi O, Oldani S, et al. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am. J. Obstet. Gynecol.175, 396–401 (1996).
   PubMed Web of Science ®Google Scholar
• Moore C, Köhler G, Muller A. The treatment of endometriosis with dienogest. Drugs Today35(Suppl. C), 41–52 (1999).
   Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, Portuese A, Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil. Steril.75, 485–488 (2001).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am. J. Obstet. Gynecol.198, 504.e1–5 (2008).
   Web of Science ®Google Scholar
• Takamura M, Koga K, Osufa Y et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum. Reprod.24, 3042–3048 (2009).
   PubMed Web of Science ®Google Scholar
• Serachioli R, Mabrouk M, Frascà C, Manuzzi L, Savelli L, Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil. Steril.94, 464–471 (2010).
   PubMed Web of Science ®Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogene (levonorgestrel): a 3 year follow-up. Hum. Reprod.20, 789–793 (2005).
   PubMed Web of Science ®Google Scholar
• Tekin YB, Dilbaz B, Altinbas SK, Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil. Steril.95, 492–496 (2011).
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum. Reprod.20, 1993–1998 (2005).
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS et al. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system. Eur. J. Obstet. Gynecol. Reprod. Biol.143, 128–129 (2009).
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprorelide acetate in the treatment of endometriosis associated pain. Hum. Reprod.21, 248–256 (2006).
   PubMed Web of Science ®Google Scholar
• Schlaff WD, Carson SA, Luciano A et al. Subcutaneous depot medroxyprogesterone acetate versus leuprorelide acetate in the treatment of endometriosis associated pain. Fertil. Steril.85, 314–325 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison RF, Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective randomized, placebo-controlled study. Fertil. Steril.74, 24–30 (2000).
   PubMed Web of Science ®Google Scholar
• Schweppe K-W. GnRH analogues: state of the art. In: GnRH Analogues. Lunenfeld B, Insler V (Eds). Parthenon Publishing Group, Carnforth, Lancaster, UK, 83–94 (1996).
   Google Scholar
• Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil. Steril.68, 393–401 (1997).
   PubMed Web of Science ®Google Scholar
• Kives S, Brown J, Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst. Rev.2, CD002122 (2000).
   Google Scholar
• Korte W, Beck KJ, Scherholz KP. Operative behandlung der endometriose und langzeittherapie mit lynestrenol. Geburtsh. u Frauenheilk.30, 122 (1979).
   Google Scholar
• Richter K, Schmidt-Tannwald I, Terruhn V. Endometriosis externa. 459 histologisch verifizierte beobachtungen. Gynäkol. Praxis5, 97 (1981).
   Google Scholar
• Hugentobler R. Die behandlung der endometriose mit hochdosiertem primolut-nor. Thesis, Zürich, Switzerland (1971).
   Google Scholar
• Schindler AE. Prognose der endometriose nach therapie. Endometriose3, 8 (1984).
   Google Scholar
• Moghissi KS, Boyce CR. Management of endometriosis with oral medroxyprogesterone acetate. Obstet. Gynecol.47, 265 (1976).
   PubMed Web of Science ®Google Scholar
• Johnston WIH. Dydrogesterone and endometriosis. Br. J. Obstet. Gynaecol.83, 77 (1976).
   PubMedGoogle Scholar